Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 437–437 | Cite as

Rituximab

Various toxicities following off-label use: 5 case reports
Case report
  • 10 Downloads

Reference

  1. D'Amico E, et al. Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience. Multiple Sclerosis and Related Disorders 27: 324-326, Jan 2019. Available from: URL: http://doi.org/10.1016/j.msard.2018.09.041 - Italy

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations